首页> 外国专利> Method for altering the expression of a target sequence of endogenous nucleic acid in a target cell, cdna transcription and target cell

Method for altering the expression of a target sequence of endogenous nucleic acid in a target cell, cdna transcription and target cell

机译:改变靶细胞内源核酸靶序列表达的方法,cdna转录和靶细胞

摘要

"METHOD TO CHANGE THE EXPRESSION OF A TARGET ENDOGENIC NUCLEIC ACID SEQUENCE IN A TARGET CELL, CDNA TRANSCRIPTION AND TARGET CELL". The present invention relates to methods for altering the expression of a target nucleic acid sequence in a target cell by producing single strand cDNA (ss-cDNA) in the target cell in vivo. The target cell is transfected with a cassette comprising a sequence of interest, an inverted conjugate repeat and a 3 'primer binding site (PBS) for the inverted conjugate repeat. Transcription of the cassette by the target cell produces an RNA template which is reverse transcribed to produce ss-cDNA of a specific sequence. The reverse transcriptase / RNase encoding gene can also be transfected into the target cell. The ss-cDNA is modified to remove all flanking vectors by taking advantage of the ss-cDNA link structure, which is formed as a result of the inverted conjugate repetition that allows the ss-cDNA to fold over itself, forming a double stranded DNA strand. The double strand chain contains one or more restriction sites for endonuclease recognition and the link, which remains as ssDNA, is comprised of the sequence of interest, which can be any desired nucleotide sequence. This design allows the double strand chain of the intermediate chain link to be cleaved by the desired corresponding endonuclease restriction (s) and the link portion of the sequence of interest is then released as a piece of DNA. single, linearized cord. This piece of ssDNA released (or cleaved) contains minimum sequence information, if any, either upstream 5 'or downstream 3' from the double strand chain. The resulting ssDNA binds to a target sequence of endogenous nucleic acid to alter the expression of that sequence for therapeutic purposes such as deactivating a gene using a double or triple bond of site-directed mutagenesis nucleic acids, disrupting cell function by binding specific cell proteins, and interfere with RNA-splitting functions.
机译:“改变靶标内源性核酸序列在靶细胞,CDNA转录和靶细胞中表达的方法”。本发明涉及通过在体内在靶细胞中产生单链cDNA(ss-cDNA)来改变靶核酸在靶细胞中表达的方法。用包含目的序列,反向缀合物重复序列和用于反向缀合物重复序列的3'引物结合位点(PBS)的盒转染靶细胞。靶细胞对盒的转录产生了RNA模板,该RNA模板被反转录以产生特定序列的ss-cDNA。逆转录酶/ RNase编码基因也可以转染到靶细胞中。通过利用ss-cDNA链接结构对ss-cDNA进行修饰,以去除所有侧翼载体,该结构是反向共轭重复的结果,它使ss-cDNA自身折叠,形成双链DNA链。双链链包含一个或多个用于核酸内切酶识别的限制性位点,并且该链保持为ssDNA,由感兴趣的序列组成,该序列可以是任何所需的核苷酸序列。这种设计允许中间链连接的双链被所需的相应核酸内切酶限制酶切割,然后将目标序列的连接部分作为一条DNA释放。单根线性线。释放(或切割)的这条ssDNA包含最小序列信息(如果有),即双链上游5'或下游3'。产生的ssDNA与内源核酸的靶序列结合,以改变该序列的表达,以达到治疗目的,例如使用定点诱变核酸的双键或三键使基因失活,通过结合特异性细胞蛋白破坏细胞功能,并干扰RNA分裂功能。

著录项

  • 公开/公告号BR0014814A

    专利类型

  • 公开/公告日2002-09-17

    原文格式PDF

  • 申请/专利权人 CYTOGENIX INC.;

    申请/专利号BR20000014814

  • 发明设计人 CHARLES A. CONRAD;

    申请日2000-10-04

  • 分类号C12N15/10;C12N15/11;C12N15/63;

  • 国家 BR

  • 入库时间 2022-08-22 00:46:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号